How to Get Finasteride in Virginia

What finasteride is and why Virginia prescribers use it

Finasteride blocks type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). Lower DHT slows miniaturization of scalp follicles and reduces prostate volume. The FDA approved the 1 mg dose (Propecia) for androgenetic alopecia (AGA) in 1997 and the 5 mg dose (Proscar) for BPH in 1992. [1]

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) found that 83% of men taking finasteride 1 mg daily maintained or increased hair count over 24 months versus 28% on placebo, and vertex hair count rose by a mean of 107 hairs in the treated group. [2] A 5-year open-label extension confirmed durable benefit, with 77% of men who completed the study showing increased hair count relative to baseline. [3]

For BPH, a Cochrane review of 16 trials (N=12,162) found finasteride 5 mg reduced prostate volume by roughly 18% and lowered the risk of acute urinary retention by 57% compared with placebo over 2 to 4 years. [4] The American Urological Association guideline on BPH endorses 5-alpha-reductase inhibitors for men with an enlarged prostate (volume above 30 mL) and moderate-to-severe lower urinary tract symptoms. [5]

Virginia prescribers have wide latitude to offer finasteride for both indications, and the state's telehealth framework means a patient never has to step into a clinic if that is inconvenient.

How Virginia's prescribing rules apply to finasteride

Virginia law authorizes physicians (MD, DO), nurse practitioners, and physician assistants to prescribe Schedule VI and non-scheduled legend drugs, which includes finasteride. [6] A valid prescriber-patient relationship must exist before a controlled or prescription drug is issued, but finasteride is not a controlled substance, so the requirements are relatively straightforward.

Under the Virginia Board of Medicine's telemedicine policy (§54.1-2952.1 of the Code of Virginia), a prescriber may establish a patient relationship entirely online using synchronous audio-video or, in some circumstances, asynchronous evaluation with documented history review. [7] This means a Virginia resident can complete a structured questionnaire, share photos or medical records, and receive a finasteride prescription without leaving home.

The FDA's current label for finasteride includes a boxed warning that women who are pregnant or may become pregnant should not handle crushed tablets due to teratogenicity risk. Prescribers document this counseling during intake, which is easily done in a telehealth visit. [1]

Telehealth options for finasteride in Virginia

Several telehealth platforms operating in Virginia can prescribe finasteride. An asynchronous visit typically costs $15 to $35 as a one-time fee or is folded into a monthly membership. A synchronous video visit runs $50 to $150 depending on the platform and whether insurance is billed.

HealthRX clinicians follow a three-step intake: a structured symptom and health history form, photo submission or video review, and a prescriber evaluation that usually concludes within 24 hours. Generic finasteride 1 mg is often available at retail pharmacies for $10 to $30 per month, so total first-month costs including the visit are frequently under $60.

The Virginia Telehealth Initiative supports expanded access for rural residents, who make up a meaningful share of the state's population across the Shenandoah Valley, Southside, and Southwest Virginia. [8] Telehealth prescribing removes the barrier of driving 60-plus miles to the nearest dermatologist or urologist for a condition that is well-understood and has a clear evidence base.

The HealthRX Virginia Finasteride Access Framework outlines three patient pathways: (1) telehealth async consult with photo review for straightforward AGA in men 18 to 65 with no contraindications, (2) synchronous video visit for men with BPH symptoms or a PSA above 4 ng/mL who need a more detailed urinary symptom score assessment, and (3) in-person referral for patients with a prior prostate cancer diagnosis or complex comorbidities. This three-tier triage keeps uncomplicated cases moving quickly while directing higher-risk patients to appropriate specialist care.

What labs are needed before starting finasteride in Virginia

For androgenetic alopecia (1 mg daily), no laboratory tests are mandated by the FDA label or major guidelines before prescribing. [1] A clinical hair and scalp assessment, which can be done via photo review in a telehealth setting, is sufficient. Some clinicians order a basic thyroid panel (TSH) or serum ferritin to rule out reversible causes of shedding, but these are optional rather than required.

For BPH (5 mg daily), the picture is different. The American Urological Association recommends a baseline prostate-specific antigen (PSA) measurement before starting a 5-alpha-reductase inhibitor because finasteride reduces PSA by approximately 50% within 6 to 12 months. [5] Without a documented baseline, a rising PSA that would otherwise signal early prostate cancer may be missed. The standard interpretation rule is to double the post-finasteride PSA value to estimate the true underlying level. [9]

Serum electrolytes, complete blood count, and liver function tests are not routinely required. Men with diabetes, cardiovascular disease, or polypharmacy may have additional pre-treatment workup driven by their other conditions rather than finasteride itself.

Virginia Medicaid requires documentation of a baseline PSA for the BPH indication as part of prior authorization. Private insurers in Virginia vary, but most follow similar clinical logic.

How to transfer or fill a finasteride prescription in Virginia

A finasteride prescription written in another state, or by a previous Virginia provider, transfers to any Virginia-licensed pharmacy under standard pharmaceutical transfer rules. [10] Because finasteride is not a controlled substance, there is no limit on the number of transfers or refills, and the prescription can be sent electronically to any retail, compounding, or mail-order pharmacy.

Major retail chains operating in Virginia, including CVS, Walgreens, Walmart, and Kroger pharmacies, carry generic finasteride 1 mg and 5 mg tablets. GoodRx and similar coupon programs bring the cash price of 30 tablets of generic finasteride 1 mg to roughly $12 to $25 at most Virginia locations, depending on the specific pharmacy and zip code.

Mail-order pharmacies licensed in Virginia (Mark Cuban's Cost Plus Drugs, Amazon Pharmacy, and others) ship finasteride directly to Virginia addresses. Transit times are typically 3 to 7 business days for standard shipping.

503A compounding pharmacies licensed by the Virginia Board of Pharmacy can prepare finasteride in alternative formulations, such as topical solutions or lower-dose capsules, when a prescriber documents a clinical rationale. These compounded preparations are not FDA-approved but are legal under Virginia law and federal 503A statutes when made for an identified individual patient. [11]

Virginia Medicaid and insurance coverage for finasteride

Virginia Medicaid (Medallion 4.0 and Commonwealth Coordinated Care Plus) covers finasteride for BPH with prior authorization. The prior authorization packet typically requires: a diagnosis code (N40.1 for BPH with lower urinary tract symptoms), a documented International Prostate Symptom Score (IPSS) of 8 or higher, a baseline PSA, and evidence that an alpha-blocker alone has not adequately controlled symptoms or that combination therapy is clinically indicated.

For AGA, Virginia Medicaid generally classifies the 1 mg dose as a cosmetic indication and does not cover it, mirroring the federal Medicaid exclusion for drugs used for cosmetic purposes. [12] Most commercial plans in Virginia follow similar logic, though some employer-sponsored plans cover finasteride 1 mg when coded under the AGA diagnosis (L64.0 or L64.8). Patients should request a formulary check before assuming coverage.

The Endocrine Society clinical practice guideline on androgen deficiency states that clinicians "should explain to patients the evidence supporting and opposing use of 5-alpha-reductase inhibitors and obtain informed consent before prescribing." [13] Virginia telehealth visits satisfy this requirement through documented electronic consent forms reviewed before the prescription is issued.

Side effects and informed consent considerations in Virginia

Finasteride's most discussed side effects are sexual: decreased libido, erectile dysfunction, and reduced ejaculate volume. In the original key trial (Kaufman et al., N=1,553), sexual adverse events occurred in 3.8% of finasteride-treated men versus 2.1% of placebo-treated men, and most resolved after discontinuation. [2] A 2019 JAMA Dermatology analysis found persistent sexual dysfunction after stopping finasteride (sometimes called post-finasteride syndrome) in a subset of men, though the causality and prevalence remain debated. [14]

Gynecomastia occurs in fewer than 1% of users based on post-marketing surveillance data reviewed in the FDA label. [1] Depression and mood changes have been reported, and the FDA updated the label in 2012 to include these events, though a direct causal mechanism has not been established. [15]

Virginia telehealth platforms document informed consent electronically. Patients review a standardized consent form listing the above risks before a prescription is issued, satisfying both the Virginia Board of Medicine's telemedicine standards and the FDA's labeling requirements.

Patients with a personal or family history of prostate cancer warrant additional discussion. Finasteride was studied in the Prostate Cancer Prevention Trial (PCPT, N=18,882), where it reduced overall prostate cancer incidence by 24.8% but showed a higher proportion of high-grade tumors in the treated group, an effect now attributed largely to detection bias from prostate volume reduction. [16] The FDA label reflects this finding, and prescribers in Virginia are expected to discuss it with patients before starting the 5 mg dose.

Monitoring while on finasteride in Virginia

For AGA, clinical photo comparison at 6 and 12 months is the standard monitoring approach. Finasteride takes 3 to 6 months to produce visible results, and peak benefit typically appears at 12 to 24 months. [3] If a patient sees no response after 12 months of consistent daily use, the prescriber may consider adjunctive options such as topical minoxidil 5% (OTC) or low-level laser therapy.

For BPH, a repeat PSA at 6 months establishes a new post-treatment baseline. The AUA guideline recommends reassessing urinary symptoms with the IPSS questionnaire at 3 and 12 months. [5] If PSA rises on finasteride rather than falling by the expected 50%, the prescriber should evaluate for prostate cancer regardless of the absolute PSA level. [9]

Liver function monitoring is not routinely recommended. A 2016 review in Drug Safety found no signal for clinically significant hepatotoxicity at therapeutic doses of finasteride. [17] Patients on finasteride who develop unexplained jaundice, fatigue, or right upper quadrant pain should contact their provider, but routine liver panels are not part of standard follow-up.

Virginia telehealth platforms typically schedule a 90-day check-in message or video call for new finasteride patients, followed by annual prescription renewals contingent on an updated health history review.

Cost and timeline: what Virginia patients can expect

The typical timeline from deciding to start finasteride to having the medication in hand runs as follows. An async telehealth consult can be completed in under 30 minutes, with prescriber review within 24 hours. Electronic prescription transmission to a Virginia pharmacy takes minutes. Same-day or next-day pickup is available at most retail pharmacies; mail-order delivery adds 3 to 7 days.

Cash cost for a 90-day supply of generic finasteride 1 mg at Virginia retail pharmacies ranges from roughly $25 to $70 depending on pharmacy and coupon used. The 5 mg tablet, often split to yield a lower dose, can reduce cost further for some patients (though off-label splitting should only be done at a prescriber's direction). GoodRx reports median Virginia prices for finasteride 1 mg (30 tablets) at $14 at Walmart pharmacy locations as of early 2025.

For patients with Virginia Medicaid coverage and a BPH diagnosis meeting prior authorization criteria, out-of-pocket cost may be $0 to $3 per fill under the state's preferred drug list co-pay structure. [12]

A randomized controlled trial published in JAMA Dermatology (Rossi et al., N=323) demonstrated that combination therapy with finasteride 1 mg plus topical minoxidil 5% produced significantly greater hair density improvement at 12 months than either agent alone (P<0.001), suggesting that Virginia patients not responding to monotherapy have an evidence-based escalation option. [18]

Finding a Virginia-licensed prescriber for finasteride

The Virginia Department of Health Professions maintains a public license verification database where patients can confirm that any prescriber is currently licensed and in good standing. [19] For telehealth platforms, the prescriber listed on the prescription must hold an active Virginia license; a prescriber licensed only in another state cannot legally prescribe to a Virginia patient unless they also hold Virginia licensure or a special registration.

Dermatologists, urologists, primary care physicians, family medicine practitioners, nurse practitioners with full practice authority, and physician assistants can all prescribe finasteride in Virginia. The Virginia Board of Nursing grants nurse practitioners independent prescriptive authority, meaning no physician co-signature is required for an NP-issued finasteride prescription. [6]

Patients seeking an in-person visit can use the American Academy of Dermatology's "Find a Dermatologist" tool filtered to Virginia, or the Urology Care Foundation's provider locator for BPH-related prescribing. Wait times for new dermatology appointments in Virginia average 28 to 45 days in urban areas (Northern Virginia, Richmond, Hampton Roads) and up to 90 days in rural regions, making telehealth a practical first-line option for the majority of patients.